New drug tested in kidney patients to see how it behaves

NCT ID NCT07217886

Recruiting now Knowledge-focused Sponsor: Shionogi Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times

Summary

This early-stage study is testing a new drug called S-892216 in about 40 people with various levels of kidney function, from normal to severe impairment. The main goal is to see how the drug moves through the body and how safe it is. Participants will be grouped by kidney function and monitored closely. This research helps doctors understand how to dose the drug properly for people with kidney problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alliance for Multispecialty Research (AMR)-Knoxville
RECRUITING

Knoxville, Tennessee, 37920, United States
Genesis Clinical Research
RECRUITING

Tampa, Florida, 33603, United States
Global Clinical Professionals (GCP) LLC
RECRUITING

St. Petersburg, Florida, 33705, United States
Orlando Clicinal Research Center
RECRUITING

Orlando, Florida, 32809, United States

Conditions

Explore the condition pages connected to this study.

RENAL IMPAIRMENT